Showing 1,041 - 1,060 results of 63,348 for search '(( 50 a decrease ) OR ( 5 ((((wt decrease) OR (we decrease))) OR (nn decrease)) ))', query time: 1.02s Refine Results
  1. 1041
  2. 1042
  3. 1043
  4. 1044
  5. 1045

    Minimal underlying data set. by Machiko K. Asaka (18334223)

    Published 2024
    “…This investigation involved measurement using the Mullen Scale of Early Learning in a representative sample of Japanese infants followed up from the age of 0 to 2 years (Nishimura et al., 2016). In the present study, we investigated the potential association between cytokine concentrations in umbilical cord serum with any of the five classes of neurodevelopmental trajectories previously assigned, as follows: high normal (N = 85, 13.0%), normal (N = 322, 49.1%), low normal (N = 137, 20.9%), delayed (N = 87, 13.3%), and markedly delayed (N = 25, 3.8%) in infancy. …”
  6. 1046
  7. 1047
  8. 1048
  9. 1049
  10. 1050
  11. 1051

    At E9.5 Actb<sup>−/−</sup> neural crest cells show a significant decrease of cadherin-11 expression. by Davina Tondeleir (426905)

    Published 2014
    “…We only observed a significant reduction of cadherin-11 intensities in Actb<sup>−/−</sup> neural crest cells at E9.5. …”
  12. 1052

    PM exposure affects small airways to a greater degree in WT compared to Ager<sup>-/-</sup> mice. by Erin J. Caraher (4445902)

    Published 2017
    “…N ≥5 mice per group. WT-PBS = 7, WT-PM = 15, Ager<sup>-/—</sup>PBS = 8, and Ager<sup>-/—</sup>PM = 7 mice were analyzed.…”
  13. 1053

    Image 5_G. vaginalis increases HSV-2 infection by decreasing vaginal barrier integrity and increasing inflammation in vivo.tif by Nuzhat Rahman (16660416)

    Published 2024
    “…On day ten, mice were inoculated with 10<sup>5</sup> PFU WT HSV-2 333 and survival, pathology, and viral titers were assessed. …”
  14. 1054
  15. 1055
  16. 1056
  17. 1057
  18. 1058
  19. 1059
  20. 1060

    Image5_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”